ABVC BioPharma, Inc. Other Accounts Payable and Accrued Liabilities
ABVC BioPharma, Inc. (ABVC) had Other Accounts Payable and Accrued Liabilities of $4.29 million as of 2025-06-30, per its 10-Q filed 2025-08-13.
Financial Statements › Notes › Payables and Accruals
us-gaap:OtherAccountsPayableAndAccruedLiabilities · last filed 2025-08-13
- 2025-06-30: Other Accounts Payable and Accrued Liabilities $4.29M.
- 2025-03-31: Other Accounts Payable and Accrued Liabilities $3.83M.
- 2024-12-31: Other Accounts Payable and Accrued Liabilities $3.51M.
- 2023-12-31: Other Accounts Payable and Accrued Liabilities $3.55M.
| Period end | Other Accounts Payable and Accrued Liabilities |
|---|---|
| 2025-06-30 | $4.29M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $3.83M 10-Q · filed 2025-04-30 |
| 2024-12-31 | $3.51M 10-Q · filed 2025-08-13 |
| 2023-12-31 | $3.55M 10-K · filed 2025-04-15 |